A combined primary end-point defined as cardiac death, recurrent non-fatal myocardial infarction and heart failure requiring hospitalization or treatment with an angiotensin-converting enzyme inhibitor and diuretic therapy was observed in 102 patients. The gene discussed is ACE; the disease is myocardial infarction.